Richard L. Shapiro

7.1k total citations · 1 hit paper
142 papers, 5.2k citations indexed

About

Richard L. Shapiro is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Richard L. Shapiro has authored 142 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Oncology, 61 papers in Molecular Biology and 56 papers in Cancer Research. Recurrent topics in Richard L. Shapiro's work include Cutaneous Melanoma Detection and Management (52 papers), Immunotherapy and Immune Responses (29 papers) and Melanoma and MAPK Pathways (27 papers). Richard L. Shapiro is often cited by papers focused on Cutaneous Melanoma Detection and Management (52 papers), Immunotherapy and Immune Responses (29 papers) and Melanoma and MAPK Pathways (27 papers). Richard L. Shapiro collaborates with scholars based in United States, India and Canada. Richard L. Shapiro's co-authors include Iman Osman, Russell S. Berman, Anna C. Pavlick, Farbod Darvishian, Daniel B. Rifkin, Daniel F. Roses, David Polsky, Ruth Oratz, Christine Ren and Paolo Mignatti and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Journal of Cell Biology.

In The Last Decade

Richard L. Shapiro

139 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fibroblast Growth Factor-2 (FGF-2) Induces Vascular Endothelial Growth Factor (VEGF) Expression in the Endothelial Cells of Forming Capillaries: An Autocrine Mechanism Contributing to Angiogenesis

1998 711 citations Richard L. Shapiro et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard L. Shapiro United States	38	2.5k	2.4k	1.6k	1.1k	720	142	5.2k
Farbod Darvishian United States	37	1.9k 0.7×	2.4k 1.0×	1.2k 0.8×	833 0.7×	472 0.7×	119	4.3k
Mark C. Kelley United States	32	1.8k 0.7×	1.6k 0.6×	1.1k 0.7×	832 0.7×	501 0.7×	56	4.7k
Isabelle Treilleux France	47	3.6k 1.5×	3.1k 1.3×	1.7k 1.1×	2.3k 2.0×	486 0.7×	219	7.9k
Léon C.L.T. van Kempen Netherlands	39	1.6k 0.6×	1.7k 0.7×	967 0.6×	661 0.6×	704 1.0×	132	4.2k
David S.P. Tan Singapore	37	2.5k 1.0×	2.2k 0.9×	1.5k 0.9×	504 0.4×	418 0.6×	181	5.1k
Jane E. Armes Australia	34	1.5k 0.6×	1.7k 0.7×	936 0.6×	1.1k 1.0×	326 0.5×	100	4.6k
David Hogg Canada	40	4.0k 1.6×	3.3k 1.3×	726 0.5×	1.2k 1.0×	366 0.5×	124	6.3k
Cyrus V. Hedvat United States	35	1.7k 0.7×	2.6k 1.1×	1.2k 0.8×	861 0.8×	296 0.4×	76	5.4k
Stanley P. L. Leong United States	43	4.4k 1.8×	2.4k 1.0×	1.4k 0.9×	1.1k 1.0×	574 0.8×	221	6.9k
Lukas C. Heukamp Germany	44	1.9k 0.8×	3.4k 1.4×	1.5k 1.0×	784 0.7×	731 1.0×	175	6.1k

Countries citing papers authored by Richard L. Shapiro

Since Specialization

Citations

This map shows the geographic impact of Richard L. Shapiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard L. Shapiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard L. Shapiro more than expected).

Fields of papers citing papers by Richard L. Shapiro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard L. Shapiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard L. Shapiro. The network helps show where Richard L. Shapiro may publish in the future.

Co-authorship network of co-authors of Richard L. Shapiro

This figure shows the co-authorship network connecting the top 25 collaborators of Richard L. Shapiro. A scholar is included among the top collaborators of Richard L. Shapiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard L. Shapiro. Richard L. Shapiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim, Randie H., Sofia Nomikou, Nicolas Coudray, et al.. (2021). Deep Learning and Pathomics Analyses Reveal Cell Nuclei as Important Features for Mutation Prediction of BRAF-Mutated Melanomas. Journal of Investigative Dermatology. 142(6). 1650–1658.e6. 27 indexed citations

Price, Alison, Freya Schnabel, Jennifer Chun, et al.. (2020). Sentinel lymph node positivity in patients undergoing mastectomies for ductal carcinoma in situ (DCIS). The Breast Journal. 26(5). 931–936. 14 indexed citations

Chou, Margaret M., Irineu Illa-Bochaca, Keith M. Giles, et al.. (2020). Using digital-image analysis of tumor-infiltrating lymphocytes to predict survival outcomes in primary melanoma.. Journal of Clinical Oncology. 38(15_suppl). 10066–10066. 1 indexed citations

Vogelsang, Matjaž, Karolina Malecek, Artur Romanchuk, et al.. (2016). The Expression Quantitative Trait Loci in Immune Pathways and their Effect on Cutaneous Melanoma Prognosis. Clinical Cancer Research. 22(13). 3268–3280. 18 indexed citations

Silva, Inês Pires da, Keith M. Giles, Matjaž Vogelsang, et al.. (2015). Identification of a Novel Pathogenic Germline KDR Variant in Melanoma. Clinical Cancer Research. 22(10). 2377–2385. 30 indexed citations

Vogelsang, Matjaž, Inês Pires da Silva, Nathaniel H. Fleming, et al.. (2015). Genetic associations of the interleukin locus at 1q32.1 with clinical outcomes of cutaneous melanoma. Journal of Medical Genetics. 52(4). 231–239. 17 indexed citations

Hanniford, Douglas, Judy Zhong, Avital Gaziel‐Sovran, et al.. (2015). A miRNA-Based Signature Detected in Primary Melanoma Tissue Predicts Development of Brain Metastasis. Clinical Cancer Research. 21(21). 4903–4912. 65 indexed citations

Fleming, Nathaniel H., Inês Pires da Silva, Richard L. Shapiro, et al.. (2014). Analysis of Recurrence Patterns in Acral Versus Nonacral Melanoma: Should Histologic Subtype Influence Treatment Guidelines?. Journal of the National Comprehensive Cancer Network. 12(12). 1706–1712. 38 indexed citations

Rose, Amy, Laura Poliseno, Jinhua Wang, et al.. (2011). Integrative Genomics Identifies Molecular Alterations that Challenge the Linear Model of Melanoma Progression. Cancer Research. 71(7). 2561–2571. 56 indexed citations

10.

Rose, Amy, Paul J. Christos, Richard L. Shapiro, et al.. (2011). Clinical Relevance of Detection of Lymphovascular Invasion in Primary Melanoma Using Endothelial Markers D2-40 and CD34. The American Journal of Surgical Pathology. 35(10). 1441–1449. 46 indexed citations

11.

Segura, Miguel F., Ilana Belitskaya‐Lévy, Amy Rose, et al.. (2010). Melanoma MicroRNA Signature Predicts Post-Recurrence Survival. Clinical Cancer Research. 16(5). 1577–1586. 173 indexed citations

12.

Warycha, Melanie, Jan Zakrzewski, Guimin Wang, et al.. (2009). Association of MDM2 SNP309, Age of Onset, and Gender in Cutaneous Melanoma. Clinical Cancer Research. 15(7). 2573–2580. 34 indexed citations

13.

Shapiro, Richard L.. (2008). How to Use POS Data in Demand Planning. 27(4). 36–4. 3 indexed citations

14.

Velázquez, Elsa F., Achim A. Jungbluth, Molly Yancovitz, et al.. (2007). Expression of the cancer/testis antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM)--correlation with prognostic factors.. PubMed Central. 7. 11–11. 97 indexed citations

15.

Yancovitz, Molly, Maryann Mikhail, Weiming Gai, et al.. (2007). Detection of Mutant BRAF Alleles in the Plasma of Patients with Metastatic Melanoma. Journal of Molecular Diagnostics. 9(2). 178–183. 34 indexed citations

16.

Naik, Arpana, et al.. (2003). Indigent breast cancer patients among all racial and ethnic groups present with more advanced disease compared withnationally reported data. The American Journal of Surgery. 186(4). 400–403. 22 indexed citations

17.

Frey, Alan B., et al.. (1998). Repression of IL-2 mRNA translation in primary human breast cancer tumor infiltrating lymphocytes. The FASEB Journal. 12(5). 1 indexed citations

18.

Reynolds, Sandra R., Ruth Oratz, Richard L. Shapiro, et al.. (1997). Stimulation of CD8 T cell responses to MAGE‐3 and Melan A/MART‐1 by immunization to a polyvalent melanoma vaccine. International Journal of Cancer. 72(6). 972–976. 3 indexed citations

19.

Reynolds, Sandra R., Ruth Oratz, Richard L. Shapiro, et al.. (1997). Stimulation of CD8+ T cell responses to MAGE-3 and Melan A/MART-1 by immunization to a polyvalent melanoma vaccine. International Journal of Cancer. 72(6). 972–976. 52 indexed citations

20.

Krinsky, Glenn A., et al.. (1997). Venous Aneurysms: MR Diagnosis with the “Layered Gadolinium” Sign. Journal of Computer Assisted Tomography. 21(4). 623–627. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact